Mechanical ThrombolysisThrombolytic TherapyStrokeFibrinolytic AgentsTissue Plasminogen ActivatorBrain IschemiaThrombectomyAcute DiseaseTreatment OutcomeInfarction, Middle Cerebral ArteryStress, MechanicalCerebrovascular DisordersTime FactorsHeparinoidsBrain InfarctionEmergency Medical ServicesCerebral InfarctionCerebral HemorrhageNeurologyStreptokinaseReperfusionNeuroprotective AgentsCerebral AngiographyIschemic Attack, TransientMyocardial InfarctionTomography, X-Ray ComputedAnticoagulantsProspective StudiesSeverity of Illness IndexRisk FactorsRetrospective StudiesInjections, Intra-ArterialClinical Trials as TopicUrokinase-Type Plasminogen ActivatorIntracranial HemorrhagesBrainPlasminogen ActivatorsMechanical ProcessesUltrasonic TherapyThrombosisDisease Models, AnimalBiomechanical PhenomenaIliac VeinFollow-Up StudiesMechanical PhenomenaMyocardial ReperfusionUnited StatesInfusions, Intra-ArterialInjections, IntravenousRecurrenceAnistreplaseCatheterization, PeripheralHeparinCoronary ThrombosisIntracranial EmbolismInfusions, IntravenousPredictive Value of TestsVascular PatencyVenous ThrombosisCarotid Artery ThrombosisStroke VolumeFemoral VeinAdministration, IntravenousCoronary AngiographyFibrinolysisRecovery of FunctionTransportation of PatientsVertebrobasilar InsufficiencyRespiration, ArtificialHemorrhageAngioplasty, Balloon, CoronaryPlatelet Aggregation InhibitorsEmbolectomyElectrocardiographyMechanotransduction, CellularCoronary Care UnitsEmergency Medical TechniciansHirudin TherapyRegistriesCohort StudiesMagnetic Resonance ImagingElasticityStentsIntracranial Embolism and ThrombosisPhysical StimulationMagnetic Resonance AngiographyAspirinPulmonary EmbolismRecombinant ProteinsEmergency TreatmentRisk AssessmentParesisArterial Occlusive DiseasesIncidenceTensile StrengthPatient SelectionElastic ModulusMiddle Cerebral ArteryPrognosisRandomized Controlled Trials as Topic